Definitive Contract HU000125CE001
- Not listed
- The Uniformed Services University of the Health Sciences awarded a delivery order valued at $805,105.60 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. for programmatic support services. This firm fixed-price contract, awarded on September 26, 2022, will be performed in Bethesda, Maryland, with an ultimate completion date of September 25, 2027. The award was made without a set-aside designation, allowing open competition among qualified contractors. The Henry M....
- This federal contract was awarded by the Uniformed Services University of the Health Sciences (USUHS), a Defense agency, to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF), a non-profit organization. The contract, valued at $6,772,255.00, is for the development of clinical practice guidelines to support the care of military-relevant infectious diseases. This is a delivery order contract with a cost-plus-fixed-fee pricing type. The ultimate completion date...
- The U.S. Navy's Bureau of Medicine and Surgery awarded a delivery order valued at $1.72M to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. for infectious disease research support services at the Naval Health Research Center (NHRC) in Westlake, Maryland. This delivery order, issued on July 27, 2012, with an ultimate completion date of August 15, 2014, operates under a Cost Plus Fixed Fee pricing structure and is not set aside for any specific business category. The...
- This is a federal contract award by the Uniformed Services University of the Health Sciences, a defense agency, to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc., a non-profit organization. The contract is for "DRUG SCREEN FOR RADIATION COMBINED INJURY IN MICE" and has a ceiling value of $767,795.00. It is a cost-plus-fixed-fee delivery order contract with a period of performance through July 22, 2027. The Henry M. Jackson Foundation holds two...
- The U.S. Navy's Bureau of Medicine and Surgery awarded a delivery order valued at $2.61 million to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Navy Medicine Research & Development Support Omnibus III indefinite delivery vehicle. The contract, awarded on November 7, 2012, with a completion date of December 5, 2014, supports biological research and field/laboratory detection of infectious diseases in support of biodefense and enhanced global disease...
- This firm-fixed-price purchase order was awarded by the U.S. Army Medical Command (MEDCOM) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) for $149,553.60. The award is for the provision of a Non-Personal Clinical Research Associate to support a follow-on continuing investigative study for clinical research at Madigan Army Medical Center in Tacoma, Washington. This contract was issued under the authority of Federal Acquisition Regulation (FAR) Subpart...
- The Defense Health Agency awarded a $77.6M cost-plus-fixed-fee contract to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on September 1, 2023, to provide non-personal support services for the Diagnostics and Countermeasures Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. The contract, with an ultimate completion date of August 31, 2028, was awarded without a set-aside designation, allowing open competition among qualified...
- The Uniformed Services University of the Health Sciences has awarded a delivery order valued at $126,502 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. for the development of interleukin-18 (IL-18) inhibitors to mitigate and treat radiation-induced acute gastrointestinal syndrome in a partial-body irradiated mouse model. This contract, awarded on July 23, 2024, with an ultimate completion date of July 22, 2027, operates under a cost-plus-fixed-fee pricing...
- The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization based in Bethesda, Maryland, received a delivery order contract award from the Bureau of Medicine and Surgery (BUMED) for Deployment Health Research Services supporting the Naval Health Research Center (NHRC) in San Diego, California. This contract modification transferred the task order to the Naval Medical Logistics Command (NMLC) and carries a ceiling value of approximately $8.3 million...
- This firm-fixed price purchase order was awarded by the U.S. Army Medical Command (MEDCOM) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $120,480.00 for the purchase of a Non-Personal Clinical Research Assistant to support a continuing clinical research study at Madigan Army Medical Center (MAMC) in Tacoma, Washington. The procurement was conducted under FAR Part 13 Simplified Acquisition Procedures and was not designated as a...
The Uniformed Services University of the Health Sciences (USUHS) awarded a definitive contract to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on September 30, 2025, for the Meningococcal Immunization Against Gonococcal Infection (MAGI) Trial/RV564. This $1.21 million cost-plus-fixed-fee contract supports a clinical research initiative focused on evaluating meningococcal vaccines for their potential effectiveness against gonococcal infection, with performance occurring in Westlake, Maryland. The award is not subject to any set-aside designation and carries an ultimate completion date of September 29, 2027. As a non-profit organization headquartered in Bethesda, Maryland, the Henry M. Jackson Foundation serves as a critical research partner to the Department of Defense and USUHS, leveraging specialized expertise in military medical research and clinical studies. This contract represents a continuation of the foundation's extensive portfolio of infectious disease research initiatives conducted on behalf of federal agencies. The MAGI trial falls within the foundation's core competency in supporting military-relevant medical research, particularly in areas of disease prevention and immunization strategy. The foundation's substantial federal presence, including its $999.999 billion OASIS+ Multiple Award Contract vehicle and additional programmatic agreements with USUHS, positions it as a key implementation partner for advancing military medical research capabilities and supporting broader public health objectives through federally funded clinical investigations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $785.2k | 9/17/25 |